NeuroPace, Inc. is a commercial-stage medical device company based in California that develops treatments for neurological disorders. The company's primary product is the RNS System, an implantable, brain-responsive neuromodulation platform designed to treat adults with drug-resistant focal epilepsy. The device continuously monitors brain activity and delivers personalized, real-time electrical pulses to prevent seizures at their source. The RNS System comprises an implantable neurostimulator, cortical strip and depth leads, and a Patient Remote Monitor. Additionally, NeuroPace provides the nSight Platform and a patient data management system, which allow clinicians to review recorded brain activity and optimize treatment. The company primarily sells its products to hospital facilities across the United States for initial implant and replacement procedures.
